Multimodality Imaging of Uterine Cervical Malignancies

Area of Science:

• Oncology
• Radiology
• Gynecologic Oncology

Background:

• Cervical cancer diagnosis and management rely heavily on accurate staging.
• The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system impacts treatment decisions.
• Advanced imaging modalities are increasingly important in cervical cancer care.

Purpose of the Study:

• To review the role of imaging in the initial staging, treatment monitoring, and follow-up of cervical cancer.
• To highlight the specific contributions of Magnetic Resonance Imaging (MRI) and Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT).
• To explore the implications of the 2018 FIGO staging system on cervical cancer management.

Main Methods:

• Review of current literature on imaging in cervical cancer.
• Focus on Magnetic Resonance Imaging (MRI) for local tumor staging.
• Emphasis on FDG PET/CT for detecting nodal and distant metastases.

Main Results:

• Imaging is vital for treatment planning and serves as a prognostic indicator in cervical cancer.
• MRI is essential for accurate local staging of the primary cervical tumor.
• FDG PET/CT is highly effective in identifying regional lymph node and distant metastases.

Conclusions:

• Imaging plays a pivotal role throughout the cervical cancer patient journey.
• MRI and FDG PET/CT offer complementary information for comprehensive staging and management.
• The integration of advanced imaging improves the precision of cervical cancer staging and prognosis assessment.